Funding

Selected projects

More than €7.5 million in competitive funding, including leadership roles in major European collaborations.

EU H2020 · Coordinator

REAP

Contrast-enhanced OCT and photoacoustic tomography for revealing drug-tolerant persister cells in cancer.

Grant agreement ID: 101016964

Duration: 1 Jan 2024 to 30 Jun 2025

€6.19M

EU H2020 FET-OPEN · Work Package Leader

Switchable magneto-plasmonic contrast agents and molecular imaging technologies.

Grant agreement ID: 899612

Duration: 1 Oct 2020 to 31 Mar 2025

€773.7K

EU MSCA Global Fellowship

Linking skin morphology and vasculature with disease using optical imaging.

Grant agreement ID: 894325

Duration: 1 Dec 2020 to 31 Oct 2023

€270K

Medical University of Vienna · Principal Investigator

A comprehensive OCT solution for skin cancer from cells to vessels.

Grant type: ϕocus M

Duration: 2022 to 2023

€49.5K